FDA Inspection 1340760 — Genesis Biosystems, Inc

Genesis Biosystems, Inc — FEI 3003427273

The FDA completed an inspection of Genesis Biosystems, Inc on Oct 8, 2026 in Lewisville, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 3 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Oct 8, 2026
Fiscal Year
2027
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Lewisville, TX (United States)

Citations

IDCFRDescription
23145ISO 13485:2016 Clause 7.4.1Records of supplier (re)evaluation, selection, and monitoring not maintained
23214ISO 13485:2016 Clause 8.2.2Complaint handling procedures not documented
23255ISO 13485:2016 Clause 8.5.2Corrective action not taken

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.